May 12 (Reuters) - Roche Group ROG.S said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly Springs, North Carolina.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.